CROI 2015 Program and Abstracts

Poster Listings

1107 Multipurpose Prevention Technologies for HIV and Pregnancy Prevention Rebecca Geary; Jennifer Smith ; Nidhi Khurana; Ide Cremin;Timothy Hallett Imperial College London, London, United Kingdom 1108 Cost-Effectiveness of Isoniazid Preventative Therapy for HIV-Infected Pregnant Women in India Sunaina Kapoor; Natasha Chida; Amita Gupta; Maunank Shah Johns Hopkins University School of Medicine, Baltimore, MD, US 1109 Epidemiologic Benefits and Cost-Effectiveness of Improving Rwanda’s HIV Care Cascade Eran Bendavid 1 ; Edward Mills 2 ; Steve Kanters 2 ; Sabin Nsanzimana 3 1 Stanford University, Stanford, CA, US; 2 University of Ottawa, Ottawa, Canada; 3 Rwanda Biomedical Center, Kigali, Rwanda 1110 The Cost-Effectiveness of Early ART Initiation in South Africa: A Quasi- Experiment Jacob Bor 1 ; Ellen Moscoe 2 ; Natsayi Chimbindi 3 ; Kobus Herbst 3 ; Kevindra K. Naidu 3 ; Frank Tanser 3 ; Deenan Pillay 3 ;Till Barnighausen 3 1 Boston University School of Public Health, Boston, MA, US; 2 Harvard School of Public Health, Boston, MA, US; 3 Wellcome Trust Africa Centre for Health and Population Studies, Somkhele, South Africa 1111 Community-Based Strategies to Strengthen the Continuum of HIV Care Are Cost-Effective Jennifer A. Smith 1 ; Monisha Sharma 2 ; Carol Levin 2 ; Jared Baeten 2 ; Heidi van Rooyen 3 ; Connie Celum 2 ;Timothy Hallett 1 ; RuanneV. Barnabas 2 1 Imperial College London, London, United Kingdom; 2 University of Washington, Seattle, WA, US; 3 Human Sciences Research Council, Sweetwaters, South Africa 1112 The Cost-Effectiveness of CD4 Cell Count Versus HIV RNA Viral Load for ART Initiation Roger Ying 1 ; BrianWilliams 3 ; RuanneV. Barnabas 1 ; Reuben Granich 2 1 University of Washington, Bellevue, WA, US; 2 Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland; 3 Stellenbosch University, Stellenbosch, South Africa 1113 Costs of Expanded HIV Testing in 4 EDs: Results FromHPTN 065 Bruce R. Schackman 1 ; Ashley A. Eggman 1 ; Jared A. Leff 1 ; Megan Braunlin 1 ; Bernard M. Branson 2 1 Weill Cornell Medical College, New York, NY, US; 2 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US 1114 Global Fund Cost Projections for ImplementingWHO 2013 Guidelines Obinna Onyekwena ; Ade Fakoya; Michael Johnson; Michael Olszak-Olszewski; Mark Dybul The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland 2:30 pm– 4:00 pm Modeling HIV Epidemiology 1115 Estimating the Number and Characteristics of Male-Male HIV Transmissions in the USA Eli S. Rosenberg 1 ; Jeremy Grey 1 ; Gabriela Paz-Bailey 2 ; H. Irene Hall 2 ; Amy Lansky 2 ; Jonathan Mermin 2 ; Jacek Skarbinski 2 1 Emory University Rollins School of Public Health, Atlanta, GA, US; 2 Centers for Disease Control and Prevention, Atlanta, GA, US; 3 CDC, Atlanta, GA, US 1116 Acute HIV Infection Transmission Among PeopleWho Inject Drugs in an Established Epidemic Setting Daniel Escudero 4 ; CalebWeinreb 4 ; Mark Lurie 4 ; Kenneth Mayer 2 ; Sandro Galea 3 ; Samuel Friedman 5 ; Brandon Marshall 4 1 Brown University, Providence, RI, US; 2 Fenway Health, Boston, MA, US; 3 Columbia University, New York, NY, US; 4 Brown University, Providence, RI, US; 5 National Development and Research Institutes, Inc, New York, NY, US WEDNESDAY, FEBRUARY 25, 2015 Session P-Z2 Poster Session Poster Hall

1117 Decreasing Number of Undiagnosed HIV Infections in the Netherlands Ard van Sighem 1 ; Fumiyo Nakagawa 3 ; Daniela De Angelis 4 ; Chantal Quinten 5 ; Daniela Bezemer 1 ; Eline Op de Coul 2 ; Matthias Egger 7 ; Frank deWolf 6 ; Christophe Fraser 6 ; Andrew N. Phillips 3 1 Stichting HIV Monitoring, Amsterdam, Netherlands; 2 National Institute for Public Health and the Environment, Bilthoven, Netherlands; 3 University College London, London, United Kingdom; 4 MRC Biostatistics Unit, Cambridge, United Kingdom; 5 Europen Centre for Disease Prevention and Control, Stockholm, Sweden; 6 Imperial College London, London, United Kingdom; 7 Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland

THURSDAY, FEBRUARY 26, 2015 Session P-Z3 Poster Session

Poster Hall

2:30 pm– 4:00 pm Modeling the Impact of HIV Interventions 1118 Predicted Impact of Antiretroviral Treatment on Preventing New HIV Infections in 53 Low- and Middle-Income Countries With Large HIV Epidemics AndrewM. Hill 1 ; Anton Pozniak 1 ; Katherine Heath 2 ; Alice Raymond 2 ; Mary Mahy 3 ; Nathan Ford 4 1 Chelsea and Westminster Hospital, London, United Kingdom; 2 St Mary’s Hospital–Imperial College Healthcare NHS Trust, London, United Kingdom; 3 Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland; 4 World Health Organization, Geneva, Switzerland 1119 Survival Benefits Attributable to the Brazilian National ART Policy Paula M. Luz 1 ; Michael P. Girouard 2 ; Beatriz Grinsztejn 1 ; Kenneth Freedberg 2 ;Valdilea Veloso 1 ; Elena Losina 4 ; Claudio Struchiner 1 ; Robert Parker 2 ; David Paltiel 3 ; RochelleWalensky 2 1 Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil; 2 Massachusetts General Hospital, Boston, MA, US; 3 Yale School of Public Health, New Haven, CT, US; 4 Brigham and Women’s Hospital, Boston, MA, US 1120 A Predictive Risk Model for First-Line Treatment Failure in South Africa Julia K. Rohr 1 ; Prudence Ive 2 ; Rebecca H. Berhanu 2 ; Kate Shearer 2 ; Mhairi Maskew 2 ; Lawrence Long 2 ; Ian Sanne 2 ; Matthew P. Fox 1 1 Boston University School of Public Health, Boston, MA, US; 2 University of Witwatersrand, Johannesburg, South Africa; 3 Right to Care, Johannesburg, South Africa 1121 U.S. Population Benefits of HIV Preexposure Prophylaxis for Injection Drug Users Cora Bernard 1 ; Margaret L. Brandeau 1 ; Douglas K. Owens 2 ; Keith Humphreys 2 ; Eran Bendavid 1 ; Mark Holodniy 2 ; ChristopherWeyant 1 ; Jeremy D. Goldhaber-Fiebert 1 1 Stanford University, Stanford, CA, US; 2 VA Palo Alto Health Care System, Palo Alto, CA, US 1122 Procreation in HIV-Serodiscordant Couples: TasP, PrEP, or Assisted Reproduction? Guillaume Mabileau 1 ; Michaël Schwarzinger 1 ; Juan Flores 1 ; Catherine Patrat 2 ; Dominique Luton 2 ; Sylvie Epelboin 2 ; Laurent Mandelbrot 3 ; Sophie Matheron 2 ;YazdanYazdanpanah 2 On behalf of ANRS 12008 1 Inserm, Paris, France; 2 AP-HP, Bichat-Claude Bernard Hospital, Paris, France; 3 Louis Mourier Hospital, Colombes, France

Poster Listings

83

CROI 2015